DarioHealth Corp. a leader in the global digital therapeutics market, announced today a strategic partnership with Amwell® a leader in digital healthcare enablement, to deliver its cardiometabolic solution to Amwell customers. Dario's solution will be available through Amwell beginning in the second half of 2023.

The agreement is part of Dario's strategy to partner with market leading strategic partners to accelerate adoption of Dario's solutions by making the Dario solution available to existing Amwell customers.  The integration into Amwell will support a more continuous and connected member journey by providing Dario's cardiometabolic solution as part of Amwell's comprehensive portfolio of care solutions and network of affiliated clinicians. Members living with cardiometabolic health concerns such as diabetes, high blood pressure and weight management challenges will have access to Dario's proven and highly personalized digital solution to help better manage their condition and improve outcomes between visits with clinicians practicing on the Amwell platform. Members can access Dario's solutions directly through Amwell's digital care delivery enablement platform to support ease of engagement.

"Amwell is a recognized leader in digital care delivery enablement covering 90 million lives through its substantial footprint of clients. We are proud to partner with them to take the Dario cardiometabolic suite to our target markets," said Rick Anderson, President of Dario. "Leveraging the power of our combined offering to enhance care and support for members, benefits everyone. This partnership fits the clear market demand for more condition solutions from less vendors and lowers the cost of delivering high value innovative digital health for buyers."

Source:prnewswire.com